Understand the source comparison
Best Research Peptides for Arthritis Research: Mechanism Comparison
BPC-157 VEGF receptor upregulation, blood-joint barrier stabilisation Cartilage degradation, tendon injury, synovial inflammation 68% reduction in synovial inflammation markers (rat CIA model, Frontiers in Immunology 2023) ≥98% purity, <0.1 EU/mg endotoxin, ve
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF receptor upregulation, blood-joint barrier stabilisation
- Cartilage degradation, tendon injury, synovial inflammation
- 68% reduction in synovial inflammation markers (rat CIA model, Frontiers in Immunology 2023)
- ≥98% purity, <0.1 EU/mg endotoxin, verified amino acid sequence
- TB-500
- Actin binding, cell migration promotion
- Tendon-to-bone healing, synovial repair, avascular cartilage zones
- 40% faster tendon healing, 54% reduction in GAG loss (University of Zagreb, multiple studies)
- ≥98% purity, residual TFA <0.1%, third-party COA
- Thymosin Alpha-1
- Treg upregulation, IL-2 receptor modulation
- Autoimmune arthritis, T-cell-mediated joint destruction
- 32% greater DAS28 reduction vs methotrexate monotherapy (Clinical Rheumatology 2021)
- ≥99% purity, endotoxin <0.05 EU/mg, lyophilised storage
- LL-37
- Antimicrobial + neutrophil modulation
- Septic arthritis, infection-related joint pathology
- 10,000-fold bacterial load reduction, 60% lower cartilage destruction (Lund University, mouse model)
- ≥97% purity, acetate salt form, refrigerated shipping